| Device |
multi-target respiratory specimen nucleic acid test including sars-cov-2 and other microbial agents |
| Definition |
A device to detect and identify nucleic acid targets in respiratory specimens from microbial agents that cause the SARS-CoV-2 respiratory infection and other microbial agents when in a multi-target test is an in vitro diagnostic device intended for the detection and identification of SARS-CoV-2 and other microbial agents when in a multi-target test in human clinical respiratory specimens from patients suspected of respiratory infection who are at risk for exposure or who may have been exposed to these agents. The device is intended to aid in the diagnosis of respiratory infection in conjunction with other clinical, epidemiologic, and laboratory data or other risk factors. |
| Physical State |
A closed system disposable pouch that contains all necessary reagents for sample preparation, reverse transcription, polymerase chain reaction (PCR), and detection from multiple respiratory pathogens from a single nasopharyngeal swab specimen. The reagent pouch is hydrated with sample buffer and specimen to activate and is placed into an automated instrument to perform the sample preparation, PCR reaction, and detection for result generation. |
| Technical Method |
A nucleic acid amplification test (NAAT). PCR-based. |
| Target Area |
Nasopharyngeal (i.e., upper respiratory) swab specimen. |
| Regulation Medical Specialty |
Microbiology |
| Review Panel |
Microbiology |
|---|
| Product Code | QOF |
|---|
| Premarket Review |
Office of In Vitro Diagnostics
(OHT7)
Division of Microbiology Devices
(DMD)
|
| Submission Type |
510(k)
|
|---|
| Regulation Number |
866.3981
|
|---|
| Device Class |
2
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction
Reporting |
Ineligible |
| Implanted Device? |
No
|
|---|
| Life-Sustain/Support Device? |
No
|
|---|
| Third Party Review |
Not Third Party Eligible |
